ETOPOPHOS Side Effects

5422010-8 | Blood Creatinine Increased, Renal Failure Acute
on Aug 20, 2007 Female patient from FRANCE , 14 years of age, was treated with Etopophos (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, renal failure acute. Etopophos dosage: 100 Milligram Lyophilisate For Parental Use(60 Mg/kg). During the same period patient was treated with THYMOGLOBULIN (Thymoglobuline- Thearpy Dates-6,8 And 9th July 2007) (View Thymoglobulin Review and Thymoglobulin Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), POLARAMINE (1 Dosage Form= 5 Mg/ml Solution) (View Polaramine Review and Polaramine Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), BACTRIM (View Bactrim Review and Bactrim Label ), ZOFRAN (View Zofran Review and Zofran Label ), ZANTAC (View Zantac Review and Zantac Label ). Patient was hospitalized.

5402730-1 | Salivary Gland Enlargement
Patient was taking Etopophos (View Usage). Patient had the following side effects: salivary gland enlargement on Jul 31, 2007 from UNITED STATES Additional patient health information: Male patient , 48 years of age, weighting 200.6 lb, . Etopophos dosage: . During the same period patient was treated with CARMUSTINE (View Carmustine Review and Carmustine Label ), GRANISETRON (View Granisetron Review and Granisetron Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), CYCLIZINE (View Cyclizine Review and Cyclizine Label ). Patient was hospitalized.

5190764-4 | Asthenia, Muscle Atrophy, Osteoarthritis
Adverse event was reported on Oct 25, 2006 by a Male patient taking Etopophos (View Usage) (Dosage: ) was diagnosed with bronchial carcinoma and. Location: GERMANY , 71 years of age, weighting 176.4 lb, After Etopophos was administered, patient had the following side effects: asthenia, muscle atrophy, osteoarthritis (What is osteoarthritis?). During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), CORTISONE ACETATE (View Cortisone Acetate Review and Cortisone Acetate Label ), ATACAND (View Atacand Review and Atacand Label ). Patient was hospitalized.

5164497-4 | Asthenia, Muscle Atrophy, Osteoarthritis
on Oct 25, 2006 Male patient from GERMANY , 71 years of age, weighting 176.4 lb, was diagnosed with bronchial carcinoma and was treated with Etopophos (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, muscle atrophy, osteoarthritis (What is osteoarthritis?). Etopophos dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), CORTISONE ACETATE (View Cortisone Acetate Review and Cortisone Acetate Label ), ATACAND (View Atacand Review and Atacand Label ). Patient was hospitalized.


5124245-0 | Dermatitis Exfoliative, Oedema Peripheral
on Oct 03, 2006 Female patient from FRANCE , child 4 years of age, was diagnosed with ewing's sarcoma and was treated with Etopophos (View Usage). Patient had the following side effects: dermatitis exfoliative, oedema peripheral. Etopophos dosage: . Patient was hospitalized.

5069615-4 | Hyperglycaemia
Patient was taking Etopophos (View Usage). After Etopophos was administered, patient had the following side effects: hyperglycaemia on Jul 27, 2006 from AUSTRALIA Additional patient health information: Female patient , 72 years of age, was diagnosed with lung neoplasm malignant, vomiting and. Etopophos dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ). Patient was hospitalized.

5055372-4 | Bone Marrow Failure, Cerebral Haemorrhage
Adverse event was reported on Jun 19, 2006 by a Female patient taking Etopophos (View Usage) (Dosage: ) was diagnosed with non-hodgkin's lymphoma recurrent and. Location: FRANCE , 49 years of age, weighting 211.6 lb, Patient experienced the following unwanted or unexpected effects: bone marrow failure, cerebral haemorrhage. During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), ARACYTINE (View Aracytine Review and Aracytine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), MABTHERA (View Mabthera Review and Mabthera Label ). Patient was hospitalized.

5039437-9 | Bone Marrow Failure, Cerebral Haemorrhage
on Jun 19, 2006 Female patient from FRANCE , 49 years of age, weighting 211.6 lb, was treated with Etopophos (View Usage). Patient had the following side effects: bone marrow failure, cerebral haemorrhage. Etopophos dosage: . During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), ARACYTINE (View Aracytine Review and Aracytine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), MABTHERA (View Mabthera Review and Mabthera Label ). Patient was hospitalized.

5029115-4 | Leukopenia
on Jun 13, 2006 Male patient from UNITED KINGDOM , 66 years of age, weighting 196.2 lb, was diagnosed with non-small cell lung cancer, anaemia of malignant disease and was treated with Etopophos (View Usage). After Etopophos was administered, patient had the following side effects: leukopenia. Etopophos dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), EPOETIN ALFA (View Epoetin Alfa Review and Epoetin Alfa Label ).

4851159-3 | Dyspnoea, Pneumocystis Jiroveci Pneumonia, Pyrexia
Patient was taking Etopophos (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, pneumocystis jiroveci pneumonia, pyrexia on Nov 18, 2005 from SWITZERLAND Additional patient health information: Female patient , 27 years of age, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Etopophos dosage: . During the same period patient was treated with BLEOMYCIN SULFATE (View Bleomycin Sulfate Review and Bleomycin Sulfate Label ), DOXORUBICIN (View Doxorubicin Review and Doxorubicin Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PROCARBAZINE (View Procarbazine Review and Procarbazine Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ). Patient was hospitalized.

4837252-X | Dyspnoea, Pneumocystis Jiroveci Pneumonia, Pyrexia
Adverse event was reported on Nov 18, 2005 by a Female patient taking Etopophos (View Usage) (Dosage: ) was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Location: SWITZERLAND , 27 years of age, Patient had the following side effects: dyspnoea, pneumocystis jiroveci pneumonia, pyrexia. During the same period patient was treated with BLEOMYCIN SULFATE (View Bleomycin Sulfate Review and Bleomycin Sulfate Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PROCARBAZINE (View Procarbazine Review and Procarbazine Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ). Patient was hospitalized.

4742848-X | Atrial Fibrillation, Dizziness, Heart Rate Increased
on Jun 17, 2005 Male patient from UNITED KINGDOM , 66 years of age, weighting 238.1 lb, was diagnosed with testicular neoplasm and was treated with Etopophos (View Usage). After Etopophos was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), dizziness (What is dizziness?), heart rate increased. Etopophos dosage: . During the same period patient was treated with PLATINEX (View Platinex Review and Platinex Label ). Patient was hospitalized.

4698937-1 | Atrial Fibrillation, Heart Rate Increased
on Jun 17, 2005 Male patient from , 66 years of age, was diagnosed with testicular neoplasm and was treated with Etopophos (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), heart rate increased. Etopophos dosage: . During the same period patient was treated with PLATINEX (View Platinex Review and Platinex Label ). Patient was hospitalized.